Assignee
MACDONALD LYNN
US·14 granted patents·1 pending application·627 citations·filing 2010–2021
Top patents by PatentIndex Score
15 records- 0199US8754287B2Mice that make heavy chain antibodiesMACDONALD LYNN·Filed 2010·Granted Jun 17, 2014·159 cites·14 claims
- 0299US8642835B2ADAM6 miceMACDONALD LYNN·Filed 2012·Granted Feb 4, 2014·133 cites·23 claims
- 0398US9035128B2Hybrid light chain miceMACDONALD LYNN·Filed 2011·Granted May 19, 2015·59 cites·19 claims
- 0498US9012717B2Human lambda light chain miceMACDONALD LYNN·Filed 2011·Granted Apr 21, 2015·61 cites·13 claims
- 0597US8309088B2Method of treating osteoarthritis with an antibody to NGFMACDONALD LYNN·Filed 2010·Granted Nov 13, 2012·77 cites·14 claims
- 0696US8148107B2High affinity human antibodies to human nerve growth factorMACDONALD LYNN·Filed 2011·Granted Apr 3, 2012·52 cites·16 claims
- 0794US9516868B2Mice that make VL binding proteinsMACDONALD LYNN·Filed 2011·Granted Dec 13, 2016·14 cites·11 claims
- 0893US8613927B2High affinity human antibodies to human nerve growth factorMACDONALD LYNN·Filed 2012·Granted Dec 24, 2013·20 cites·16 claims
- 0992US8658154B2Humanized FcγR miceMACDONALD LYNN·Filed 2010·Granted Feb 25, 2014·9 cites·15 claims
- 1091US8658853B2Low affinity FcγR deficient miceMACDONALD LYNN·Filed 2012·Granted Feb 25, 2014·7 cites·9 claims
- 1190US8425907B2Methods for treating pruritus by administering an antibody that specifically binds human PAR2MACDONALD LYNN·Filed 2011·Granted Apr 23, 2013·14 cites·6 claims
- 1288US8883496B2Humanized FcgR miceMACDONALD LYNN·Filed 2011·Granted Nov 11, 2014·9 cites·11 claims
- 1387US8101724B2High-affinity human antibodies to human protease-activated receptor-2MACDONALD LYNN·Filed 2010·Granted Jan 24, 2012·10 cites·6 claims
- 1472US8871996B2Mice expressing human voltage-gated sodium channelsMACDONALD LYNN·Filed 2011·Granted Oct 28, 2014·3 cites·23 claims
- 1569US2021368751A1Humanized rodents that express heavy chain containing vl domainsMACDONALD LYNN·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →